London's AIM welcomes Arthro Kinetics:
This article was originally published in Clinica
Stuttgart, Germany-based orthopaedics company Arthro Kinetics has begun trading its shares on the Alternative Investment Market at the London stock exchange, following the placement of nearly 5 million shares priced at 120p ($2.10) each. Some £6m was raised in total from the public offering, proceeds which will be used to complete US clinical trials of the firm's cartilage regeneration system, CaReS, and advance its product pipeline (see Clinica No 1195, p 15). The company's market capitalisation at the placing price is £33m.